Human Metapneumovirus–associated Infections Among American Indian and Alaska Native Children, 2019–2024
BACKGROUND: Data on human metapneumovirus (HMPV)-associated acute respiratory infections (ARI) among American Indian/Alaska Native (AI/AN) children are lacking publications. METHODS: We conducted active ARI surveillance among hospitalized and outpatient AI/AN children <5 years of age at select facilities in Navajo Nation, White Mountain Apache Tribal lands, and Alaska (Anchorage and Yukon-Kuskokwim Delta). Children meeting a symptom-based ARI case definition from November 2019 to May 2024 were eligible. Data were collected via questionnaire and chart review. Mid-turbinate nasal swabs were tested for HMPV and other respiratory pathogens by polymerase chain reaction. Incidence rates of HMPV-associated hospitalization were calculated using Poisson regression. Seasonality was described, and risk factors for HMPV-associated hospitalization were assessed using Poisson multivariable modeling with robust standard errors. RESULTS: Overall, 13.0% (218/1683) of children hospitalized with ARI and 7.0% (81/1165) of outpatient children with ARI were HMPV-positive. HMPV generally circulated December through May; seasonality and incidence were disrupted by the coronavirus disease 2019 pandemic. In 2023-2024, incidence rates of HMPV-associated ARI hospitalization per 1000 children <5 years old were 11.3 (95% confidence interval: 8.6-14.8) in the Southwest, 10.3 (7.4-14.4) in the Yukon-Kuskokwim Delta, and 0 (0-1.1) in Anchorage. In the Poisson model, age <2 years (adjusted risk ratio: 1.43 [1.08-1.90]) and presenting to care ≥4 days after illness onset (1.38 [1.09-1.75]) were significantly associated with increased risk for HMPV-associated hospitalization compared with HMPV-associated outpatient visits. CONCLUSIONS: This analysis documents the burden of HMPV-associated ARI and hospitalization among AI/AN children <5 years of age as a baseline to inform the use of future pediatric HMPV prevention products.
Authors
- Mila M. Prill (ORCID: https://orcid.org/0000-0002-1175-417X)
- Fatimah S. Dawood (ORCID: https://orcid.org/0000-0002-6609-376X)
- Sainimere Boladuadua (ORCID: https://orcid.org/0000-0002-0768-0454)
- Rosalyn J. Singleton (ORCID: https://orcid.org/0000-0002-0317-3789)
- Rachel M. Hartman (ORCID: https://orcid.org/0000-0002-6837-4629)
- Christine Desnoyers
- Jessica E. Atwell (ORCID: https://orcid.org/0000-0003-1169-6456)
- Kelly Menachof
- Meredith McMorrow (ORCID: https://orcid.org/0000-0001-6363-4033)
- Catherine Gayle Sutcliffe (ORCID: https://orcid.org/0000-0001-8512-8326)
- Carol Tso
- Kristen Roessler (ORCID: https://orcid.org/0009-0004-3198-2622)
- Amanda B. Burrage (ORCID: https://orcid.org/0000-0002-8577-9433)
- James B. Mcauley (ORCID: https://orcid.org/0009-0006-5590-5618)
- Amy Swango-Wilson
- Laura L. Hammitt (ORCID: https://orcid.org/0000-0001-6051-1484)
- James W. Keck (ORCID: https://orcid.org/0000-0001-7193-065X)
- Danika Bailie
- James D. Chappell (ORCID: https://orcid.org/0000-0002-7382-7864)
- Angela P. Campbell (ORCID: https://orcid.org/0000-0002-2576-482X)
- Juan de Dios Luna
- Chloe Hurley
- Nikki Anderson
- Loretta Christensen (ORCID: https://orcid.org/0000-0002-5591-9845)
- Dennie Parker Riley
- Gilberto Alvarez-Colon
- Lauryl Torkelson (ORCID: https://orcid.org/0009-0007-5953-927X)
- Joel S. Espinoza (ORCID: https://orcid.org/0009-0006-4260-5878)
- Natasha Halasa
- Angel Vasquez
Institutions
- Centers for Disease Control and Prevention (US)
- Alaska Native Tribal Health Consortium (US)
- Johns Hopkins University (US)
- Indian Health Service (US)
- Pfizer (United States) (US)
- Yukon Kuskokwim Health Corporation (US)
- Tsehootsooi Medical Center (US)
- Gallup Indian Medical Center (US)
- Tuba City Regional Health Care (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- The Pediatric Infectious Disease Journal
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1097/inf.0000000000005469
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00